A central theory behind covax, is that if nations are competing for intellectual and pharmaceutical resources, this would slow development.  Instead, covax supports communication and pools money from all nations, taking advantage of an economy of scale.  Investment in covax vaccine development is portrayed by the world health organization as a form of “insurance.” 

Covax Vaccine Development

Failure to collaborate could also lead to hoarding within the nation which successfully develops the first successful vaccine, followed by intense competition between wealthy states for remaining vaccines.  Instead, covax has guaranteed equitable distribution to all participating nations, ensuring vaccination of a minimum of 20% of the population, namely those who meet at-risk criteria.   It is also notable that having vaccines distributed across economic zones will be more helpful in rebooting the international economy than having a handful of nation with high rates of vaccination at the expense of other nations.  The group aims to produce 2 billion doses of the vaccine by the end of 2021. 

Covax Vaccine Distribution

In early September, The United States made an official statement that the nation does not intend to join the Covax coalition, in line with President Trump’s general frustration with WHO’s early response to the pandemic.  This policy has been controversial within the public health community, to politicians within the Democratic party, and even within the Trump administration itself.  China is another notable exception to the Covax coalition as of early September, but talks have indicated that this is subject to change.

Notable Nonparticipation in Covax

In early summer of 2020, 170 countries joined the World Health Organization’s efforts to develop and equitably distribute a covid-19 vaccine to the most vulnerable, a plan referred to as COVAX.  This is a joint project with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, and the Vaccine Alliance.  Covax holds the largest portfolio of covid-19 vaccine candidates in the world.  

University of California, Davis

- Nursing Students Working Before Graduation Policy 
- Telemedicine Policies Changes Due to COVID-19
- Covax: An International Vaccine Effort

Medical Policies in Response to COVID-19

World Health Organization. (2020). The COVAX facility: Global procurement for COVID-19 Vaccines. Retrieved from https://www.gavi.org/sites/default/files/covid/COVAX-Facility-background.pdf

The COVAX facility: Global procurement for COVID-19 Vaccines

Nursing students have experience with patient care in a clinical setting for hundreds and thousands of hours due to their education program. Therefore, states are allowing nursing students who are nearing graduation or recently graduated but have not passed their NCLEX (National Council Licensure Examination) exam. 
- Problems with Student Nurses Working Early

Nursing Students Working Before Graduation Policy 

There are policy changes around financial, technical, and regulations due to the COVID-19 policies. These changes will terminate with the public health emergency ending. 
- Financial Changes
- Technical Changes
- Changes in Regulations

Learn Before

Related

Learn After